-
Something wrong with this record ?
A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients
D. Dudas, TJ. Dilling, IE. Naqa
Language English Country England, Great Britain
Document type Journal Article
Grant support
R01-CA233487
NIH HHS - United States
R01-CA233487
NIH HHS - United States
R01-CA233487
NIH HHS - United States
W81XWH-22-1-0277
Congressionally Directed Medical Research Programs
W81XWH-22-1-0277
Congressionally Directed Medical Research Programs
W81XWH-22-1-0277
Congressionally Directed Medical Research Programs
NLK
BioMedCentral
from 2006-12-01
BioMedCentral Open Access
from 2006
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
Springer Nature OA/Free Journals
from 2006-12-01
- MeSH
- Radiotherapy Dosage * MeSH
- Deep Learning * MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Metastasis MeSH
- Lung Neoplasms * pathology radiotherapy MeSH
- Carcinoma, Non-Small-Cell Lung * radiotherapy pathology MeSH
- Radiotherapy Planning, Computer-Assisted methods MeSH
- Prognosis MeSH
- Radiosurgery * methods MeSH
- Radiotherapy, Intensity-Modulated methods MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: Recent papers suggested a correlation between the risk of distant metastasis (DM) and dose outside the PTV, though conclusions in different publications conflicted. This study resolves these conflicts and provides a compelling explanation of prognostic factors. MATERIALS AND METHODS: A dataset of 478 NSCLC patients treated with SBRT (IMRT or VMAT) was analyzed. We developed a deep learning model for DM prediction and explainable AI was used to identify the most significant prognostic factors. Subsequently, the prognostic power of the extracted features and clinical details were analyzed using conventional statistical methods. RESULTS: Treatment technique, tumor features, and dosiomic features in a 3 cm wide ring around the PTV (PTV3cm) were identified as the strongest predictors of DM. The Hazard Ratio (HR) for Dmean,PTV3cm was significantly above 1 (p < 0.001). There was no significance of the PTV3cm dose after treatment technique stratification. However, the dose in PTV3cm was found to be a highly significant DM predictor (HR > 1, p = 0.004) when analyzing only VMAT patients with small and spherical tumors (i.e., sphericity > 0.5). CONCLUSIONS: The main reason for conflicting conclusions in previous papers was inconsistent datasets and insufficient consideration of confounding variables. No causal correlation between the risk of DM and dose outside the PTV was found. However, the mean dose to PTV3cm can be a significant predictor of DM in small spherical targets treated with VMAT, which might clinically imply considering larger PTV margins for smaller, more spherical tumors (e.g., if IGTV > 2 cm, then margin ≤ 7 mm, else margin > 7 mm).
Department of Machine Learning H Lee Moffitt Cancer Center and Research Institute Tampa FL USA
Department of Radiation Oncology H Lee Moffitt Cancer Center and Research Institute Tampa FL USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018844
- 003
- CZ-PrNML
- 005
- 20241024111115.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13014-024-02519-1 $2 doi
- 035 __
- $a (PubMed)39334387
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Dudas, D $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czechia. dudasden@fjfi.cvut.cz
- 245 12
- $a A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients / $c D. Dudas, TJ. Dilling, IE. Naqa
- 520 9_
- $a PURPOSE: Recent papers suggested a correlation between the risk of distant metastasis (DM) and dose outside the PTV, though conclusions in different publications conflicted. This study resolves these conflicts and provides a compelling explanation of prognostic factors. MATERIALS AND METHODS: A dataset of 478 NSCLC patients treated with SBRT (IMRT or VMAT) was analyzed. We developed a deep learning model for DM prediction and explainable AI was used to identify the most significant prognostic factors. Subsequently, the prognostic power of the extracted features and clinical details were analyzed using conventional statistical methods. RESULTS: Treatment technique, tumor features, and dosiomic features in a 3 cm wide ring around the PTV (PTV3cm) were identified as the strongest predictors of DM. The Hazard Ratio (HR) for Dmean,PTV3cm was significantly above 1 (p < 0.001). There was no significance of the PTV3cm dose after treatment technique stratification. However, the dose in PTV3cm was found to be a highly significant DM predictor (HR > 1, p = 0.004) when analyzing only VMAT patients with small and spherical tumors (i.e., sphericity > 0.5). CONCLUSIONS: The main reason for conflicting conclusions in previous papers was inconsistent datasets and insufficient consideration of confounding variables. No causal correlation between the risk of DM and dose outside the PTV was found. However, the mean dose to PTV3cm can be a significant predictor of DM in small spherical targets treated with VMAT, which might clinically imply considering larger PTV margins for smaller, more spherical tumors (e.g., if IGTV > 2 cm, then margin ≤ 7 mm, else margin > 7 mm).
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nemalobuněčný karcinom plic $x radioterapie $x patologie $7 D002289
- 650 12
- $a nádory plic $x patologie $x radioterapie $7 D008175
- 650 12
- $a deep learning $7 D000077321
- 650 12
- $a radiochirurgie $x metody $7 D016634
- 650 12
- $a celková dávka radioterapie $7 D011879
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a radioterapie s modulovanou intenzitou $x metody $7 D050397
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a plánování radioterapie pomocí počítače $x metody $7 D011880
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a metastázy nádorů $7 D009362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dilling, T J $u Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
- 700 1_
- $a Naqa, I El $u Department of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
- 773 0_
- $w MED00165460 $t Radiation oncology (London, England) $x 1748-717X $g Roč. 19, č. 1 (2024), s. 127
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39334387 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111109 $b ABA008
- 999 __
- $a ok $b bmc $g 2201609 $s 1230817
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 19 $c 1 $d 127 $e 20240927 $i 1748-717X $m Radiation oncology (London, England) $n Radiat Oncol $x MED00165460
- GRA __
- $a R01-CA233487 $p NIH HHS $2 United States
- GRA __
- $a R01-CA233487 $p NIH HHS $2 United States
- GRA __
- $a R01-CA233487 $p NIH HHS $2 United States
- GRA __
- $a W81XWH-22-1-0277 $p Congressionally Directed Medical Research Programs
- GRA __
- $a W81XWH-22-1-0277 $p Congressionally Directed Medical Research Programs
- GRA __
- $a W81XWH-22-1-0277 $p Congressionally Directed Medical Research Programs
- LZP __
- $a Pubmed-20241015